Stay updated on Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial page.

Latest updates to the Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page’s Locations section was updated with additions and removals of study sites across multiple states and countries (e.g., CA, CT, FL, KY, NY, NC, OH, TN, UT, WA, and European locations).SummaryDifference1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2 with no changes to the study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check48 days agoChange DetectedNotice about government funding and NIH operating status was removed from the page. This change does not alter the study details, eligibility criteria, or results.SummaryDifference0.3%

- Check62 days agoChange DetectedThe study record now includes posted results with a new 'Results First Posted' date (2025-01-27) and updated QC-related study dates.SummaryDifference0.3%

- Check91 days agoChange DetectedUpdate: page version bumped to v3.2.0 with an added government operating status notice; removal of the v3.1.0 tag. Overall, signals a status and version update rather than a change to core content.SummaryDifference2%

- Check98 days agoChange DetectedUpgrade version from v3.0.2 to v3.1.0; no other content changes are specified.SummaryDifference0.0%

Stay in the know with updates to Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial page.